vs
COVENANT LOGISTICS GROUP, INC.（CVLG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
COVENANT LOGISTICS GROUP, INC.的季度营收约是Orthofix Medical Inc.的1.4倍（$307.2M vs $219.9M），COVENANT LOGISTICS GROUP, INC.净利率更高（1.4% vs -1.0%，领先2.4%），COVENANT LOGISTICS GROUP, INC.同比增速更快（14.0% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 3.4%）
圣约物流集团（Covenant Logistics Group, Inc.）是一家美国公路货运企业，总部位于田纳西州查塔努加，在纽约证券交易所上市。公司核心业务涵盖温控卡车运输、区域配送以及长途团队司机货运服务，专注于整车运输领域。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CVLG vs OFIX — 直观对比
营收规模更大
CVLG
是对方的1.4倍
$219.9M
营收增速更快
CVLG
高出12.1%
2.0%
净利率更高
CVLG
高出2.4%
-1.0%
两年增速更快
OFIX
近两年复合增速
3.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $307.2M | $219.9M |
| 净利润 | $4.4M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 2.0% | 0.2% |
| 净利率 | 1.4% | -1.0% |
| 营收同比 | 14.0% | 2.0% |
| 净利润同比 | -32.7% | 92.4% |
| 每股收益（稀释后） | $0.17 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVLGOFIX
| Q1 26 | $307.2M | — | ||
| Q4 25 | $295.4M | $219.9M | ||
| Q3 25 | $296.9M | $205.6M | ||
| Q2 25 | $302.9M | $203.1M | ||
| Q1 25 | $269.4M | $193.6M | ||
| Q4 24 | $277.3M | $215.7M | ||
| Q3 24 | $287.9M | $196.6M | ||
| Q2 24 | $287.5M | $198.6M |
净利润CVLGOFIX
| Q1 26 | $4.4M | — | ||
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $9.1M | $-22.8M | ||
| Q2 25 | $9.8M | $-14.1M | ||
| Q1 25 | $6.6M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $13.0M | $-27.4M | ||
| Q2 24 | $12.2M | $-33.4M |
毛利率CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率CVLGOFIX
| Q1 26 | 2.0% | — | ||
| Q4 25 | -8.2% | 0.2% | ||
| Q3 25 | 2.7% | -8.3% | ||
| Q2 25 | 3.8% | -7.9% | ||
| Q1 25 | 2.8% | -25.2% | ||
| Q4 24 | 3.1% | -5.3% | ||
| Q3 24 | 5.6% | -9.6% | ||
| Q2 24 | 5.4% | -12.5% |
净利率CVLGOFIX
| Q1 26 | 1.4% | — | ||
| Q4 25 | — | -1.0% | ||
| Q3 25 | 3.1% | -11.1% | ||
| Q2 25 | 3.2% | -6.9% | ||
| Q1 25 | 2.4% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 4.5% | -13.9% | ||
| Q2 24 | 4.2% | -16.8% |
每股收益（稀释后）CVLGOFIX
| Q1 26 | $0.17 | — | ||
| Q4 25 | $-0.68 | $-0.05 | ||
| Q3 25 | $0.35 | $-0.57 | ||
| Q2 25 | $0.36 | $-0.36 | ||
| Q1 25 | $0.24 | $-1.35 | ||
| Q4 24 | $0.25 | $-0.76 | ||
| Q3 24 | $0.47 | $-0.71 | ||
| Q2 24 | $0.44 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $407.6M | $450.0M |
| 总资产 | $1.0B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $4.9M | $82.0M | ||
| Q3 25 | $2.7M | $62.9M | ||
| Q2 25 | $143.0K | $65.6M | ||
| Q1 25 | $11.2M | $58.0M | ||
| Q4 24 | $35.6M | $83.2M | ||
| Q3 24 | $35.2M | $30.1M | ||
| Q2 24 | $1.3M | $26.4M |
总债务CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $261.7M | — | ||
| Q3 25 | $233.3M | $157.2M | ||
| Q2 25 | $245.8M | $157.0M | ||
| Q1 25 | $216.3M | $156.9M | ||
| Q4 24 | $221.6M | $157.0M | ||
| Q3 24 | $231.4M | $118.5M | ||
| Q2 24 | $235.0M | $118.0M |
股东权益CVLGOFIX
| Q1 26 | $407.6M | — | ||
| Q4 25 | $404.0M | $450.0M | ||
| Q3 25 | $423.7M | $442.5M | ||
| Q2 25 | $416.9M | $458.3M | ||
| Q1 25 | $443.6M | $458.3M | ||
| Q4 24 | $438.3M | $503.1M | ||
| Q3 24 | $431.6M | $525.9M | ||
| Q2 24 | $419.4M | $546.0M |
总资产CVLGOFIX
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $850.6M | ||
| Q3 25 | $1.0B | $832.6M | ||
| Q2 25 | $1.0B | $837.2M | ||
| Q1 25 | $980.0M | $823.1M | ||
| Q4 24 | $997.6M | $893.3M | ||
| Q3 24 | $1.0B | $867.9M | ||
| Q2 24 | $995.0M | $882.0M |
负债/权益比CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.65× | — | ||
| Q3 25 | 0.55× | 0.36× | ||
| Q2 25 | 0.59× | 0.34× | ||
| Q1 25 | 0.49× | 0.34× | ||
| Q4 24 | 0.51× | 0.31× | ||
| Q3 24 | 0.54× | 0.23× | ||
| Q2 24 | 0.56× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $25.5M | $27.7M | ||
| Q3 25 | $41.4M | $12.4M | ||
| Q2 25 | $21.9M | $11.6M | ||
| Q1 25 | $24.8M | $-18.4M | ||
| Q4 24 | $21.9M | $23.7M | ||
| Q3 24 | $56.9M | $11.7M | ||
| Q2 24 | $22.4M | $9.0M |
自由现金流CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-3.0M | $16.8M | ||
| Q3 25 | $-7.8M | $2.5M | ||
| Q2 25 | $-14.5M | $4.5M | ||
| Q1 25 | $-8.6M | $-25.1M | ||
| Q4 24 | $464.0K | $15.2M | ||
| Q3 24 | $24.3M | $6.3M | ||
| Q2 24 | $-28.1M | $-360.0K |
自由现金流率CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 7.6% | ||
| Q3 25 | -2.6% | 1.2% | ||
| Q2 25 | -4.8% | 2.2% | ||
| Q1 25 | -3.2% | -13.0% | ||
| Q4 24 | 0.2% | 7.0% | ||
| Q3 24 | 8.4% | 3.2% | ||
| Q2 24 | -9.8% | -0.2% |
资本支出强度CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | 9.7% | 4.9% | ||
| Q3 25 | 16.6% | 4.8% | ||
| Q2 25 | 12.0% | 3.5% | ||
| Q1 25 | 12.4% | 3.5% | ||
| Q4 24 | 7.7% | 4.0% | ||
| Q3 24 | 11.3% | 2.7% | ||
| Q2 24 | 17.6% | 4.7% |
现金转化率CVLGOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.55× | — | ||
| Q2 25 | 2.23× | — | ||
| Q1 25 | 3.78× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.36× | — | ||
| Q2 24 | 1.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVLG
| Freight revenue | $281.9M | 92% |
| Other | $25.2M | 8% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
